SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-24-105483
Filing Date
2024-04-22
Accepted
2024-04-22 20:35:27
Documents
2
Group Members
BIOTECH GROWTH N.V.

Document Format Files

Seq Description Document Type Size
1 SC 13G d807203dsc13g.htm SC 13G 51710
2 EX-99.A d807203dex99a.htm EX-99.A 8238
  Complete submission text file 0001193125-24-105483.txt   61606
Mailing Address SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 8200
Business Address SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 8200 411724 59 59
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000

Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Subject) CIK: 0001528115 (see all company filings)

IRS No.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91583 | Film No.: 24862481
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)